Neuromod Welcomes New Executives to Enhance Tinnitus Care Expansion

Neuromod's Strategic Enhancements with New Leadership

Neuromod Devices, a pioneering medical technology company focused on innovative treatments for tinnitus, has recently made significant senior appointments that promise to reshape its commercial landscape and expand patient access to its groundbreaking treatment device, Lenire. The company has announced Joe Ghiz as its new Chief Commercial Officer (CCO) and Shannon Basham as Vice President of Channel Development. These appointments come at a crucial time as Neuromod aims to bolster its market presence amid increasing demand for effective tinnitus solutions.

Leadership Induction

Joe Ghiz, joining from Align Technology where he played a pivotal role in the development and market adoption of the Invisalign system, will spearhead Neuromod's global commercial strategies. With a strong track record in creating new categories in medical care and rapid business expansion, Ghiz's expertise is expected to be instrumental in guiding the company towards achieving its goal of reaching over 740 million people suffering from tinnitus worldwide.

In welcoming Ghiz, Dr. Ross O'Neill, CEO of Neuromod, emphasized the significance of this strategic recruitment during a period of comprehensive clinical validations and market readiness for Lenire, the first non-invasive bimodal neuromodulation device approved for tinnitus treatment. Ghiz expressed enthusiasm about his new role, highlighting the transformative impact Lenire has had on patients' lives and indicating an ambitious vision for the treatment's future reach and normalization in ENT practices globally.

Shannon Basham, with over two decades of experience in the hearing care industry, will oversee the channel development strategies. Her previous position as the Senior Director of Audiology for Sonova Group underscores her vast knowledge and skills in enhancing audiology services and helps in upstreaming a robust strategy that aligns with Neuromod's vision.

The Future of Tinnitus Treatment

Lenire offers a revolutionary approach to tinnitus treatment, combining auditory stimulation with electrical impulses to the tongue, delivered by a proprietary device called Tonguetip®. Patients can use Lenire at home under the guidance of healthcare professionals, ensuring that the treatment is both effective and convenient. As evidence supporting Lenire’s effectiveness mounts, Ghiz and Basham are set to leverage their extensive backgrounds to ensure that the device becomes a standard treatment offered in ENT and audiology clinics worldwide.

Ghiz’s previous leadership roles at Align Technology and Johnson & Johnson give him a unique insight into how to communicate the benefits of innovative treatment technologies to both healthcare providers and patients. As a leader, he has consistently focused on creating value through strategic initiative designs and collaborative efforts with industry stakeholders, which will align well with Neuromod's goals.

Basham’s transition to Neuromod aligns perfectly with the current strategic plans of the company, aiming to create educational pathways and enhance the sales approach towards audiology practices. With her direction, Neuromod anticipates driving widespread adoption by ensuring that audiologists are not just aware of Lenire, but actively engaged as champions for its use across their practices.

Conclusion

With Joe Ghiz and Shannon Basham at the helm of Neuromod's commercial strategy and channel development respectively, the company is poised for substantial growth in the tinnitus market. Their collective experience and passion for healthcare innovation will undoubtedly accelerate the journey to making Lenire a go-to solution in tinnitus care, ultimately bringing relief to millions suffering from this complex condition. As Neuromod continues its mission, the commitment to effectively support those with tinnitus remains stronger than ever, promising a new dawn in treatment accessibility and quality of care, essential for improving patient outcomes.

For more information about Neuromod Devices and their groundbreaking tinnitus treatment, please visit Neuromod's official website.